ARNO nasce da una collaborazione tra il CINECA e i servizi farmaceutici delle ASL con l’obiettivo di costituire un osservatorio come base informativa, con il paziente al centro del processo, per la programmazione sia clinica che sanitaria.
Pubblicazioni
Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory. Bonora E, Cataudella S, Marchesini G, Miccoli R, Vaccaro O, Fadini GP, Martini N, Rossi E; mandate of the Italian Diabetes Society. Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2661-2668. doi: 10.1016/j.numecd.2021.06.006.
Incidence of diabetes mellitus in Italy in year 2018. A nationwide population-based study of the ARNO Diabetes Observatory. Bonora E, Cataudella S, Marchesini G, Miccoli R, Vaccaro O, Fadini GP, Martini N, Rossi E; under the mandate of the Italian Diabetes Society. Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2338-2344. doi: 10.1016/j.numecd.2021.04.017.
A view on the quality of diabetes care in Italy and the role of Diabetes Clinics from the 2018 ARNO Diabetes Observatory. Bonora E, Cataudella S, Marchesini G, Miccoli R, Vaccaro O, Fadini GP, Martini N, Rossi E. Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1945-1953. doi: 10.1016/j.numecd.2020.08.018.
Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory. Bonora E, Cataudella S, Marchesini G, Miccoli R, Vaccaro O, Fadini GP, Martini N, Rossi E; under the mandate of the Italian Diabetes Society. BMJ Open Diabetes Res Care. 2020 Jul;8(1):e001191. doi: 10.1136/bmjdrc-2020-001191
Use of lipid lowering drugs in patients at very high risk of cardiovascular events: An analysis on nearly 3,000,000 Italian subjects of the ARNO Observatory. Maggioni AP, Calabria S, Rossi E, Martini N; on the behalf of the ARNO Observatory. Int J Cardiol. 2017 Nov 1;246:62-67. doi: 10.1016/j.ijcard.2017.02.108.
Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012. Bruno G, Pagano E, Rossi E, Cataudella S, De Rosa M, Marchesini G, Miccoli R, Vaccaro O, Bonora E. Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1104-1111. doi: 10.1016/j.numecd.2016.09.002.
Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study. Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N. Clinicoecon Outcomes Res. 2016 Aug 4;8:407-12. doi: 10.2147/CEOR.S111535. eCollection 2016.
The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory. Pagano E, De Rosa M, Rossi E, Cinconze E, Marchesini G, Miccoli R, Vaccaro O, Bonora E, Bruno G. Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):944-50. doi: 10.1016/j.numecd.2016.05.002.
Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis. Calabria S, Cinconze E, Rossini M, Rossi E, Maggioni AP, Pedrini A, De Rosa M. Patient Prefer Adherence. 2016 Apr 19;10:523-30. doi: 10.2147/PPA.S95634. eCollection 2016.
State-of-the-Art Review on Diabetes Care in Italy. Disoteo O, Grimaldi F, Papini E, Attanasio R, Tonutti L, Pellegrini MA, Guglielmi R, Borretta G. Ann Glob Health. 2015 Nov-Dec;81(6):803-13. doi: 10.1016/j.aogh.2015.12.013.
The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database. Maggioni AP, Orso F, Calabria S, Rossi E, Cinconze E, Baldasseroni S, Martini N; ARNO Observatory. Eur J Heart Fail. 2016 Apr;18(4):402-10. doi: 10.1002/ejhf.471. Epub 2016 Jan 11.
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs. Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M. Hepat Med. 2015 Jul 13;7:37-42. doi: 10.2147/HMER.S87594. eCollection 2015.
Under-treatment of migrants with diabetes in a universalistic health care system: the ARNO Observatory. Marchesini G, Bernardi D, Miccoli R, Rossi E, Vaccaro O, De Rosa M, Bonora E, Bruno G. Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):393-9. doi: 10.1016/j.numecd.2013.09.012.
Use and misuse of statins after ACS: analysis of a prescription database of a community setting of 2,042,968 subjects. Maggioni AP, Rossi E, Cinconze E, De Rosa M; ARNO Cardiovascular Observatory. Eur J Prev Cardiol. 2014 Sep;21(9):1109-16. doi: 10.1177/2047487313485511.
Outcomes, health costs and use of antiplatelet agents in 7,082 patients admitted for an acute coronary syndrome occurring in a large community setting. Maggioni AP, Rossi E, Cinconze E, Roggeri DP, Roggeri A, Fabbri G, De Rosa M; ARNO Cardiovascular Observatory. Cardiovasc Drugs Ther. 2013 Aug;27(4):333-40. doi: 10.1007/s10557-013-6455-z.
Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation. Roggeri DP, Roggeri A, Rossi E, Cinconze E, De Rosa M, Maggioni AP; ARNO Cardiovascular Observatory. Eur J Prev Cardiol. 2014 Sep;21(9):1090-6. doi: 10.1177/2047487313483608.
Antidiabetic therapy in real practice: indicators for adherence and treatment cost. Colombo GL, Rossi E, De Rosa M, Benedetto D, Gaddi AV. Patient Prefer Adherence. 2012;6:653-61. doi: 10.2147/PPA.S33968.
Quality of diabetes care in Italy: information from a large population-based multiregional observatory (ARNO diabetes). Bruno G, Bonora E, Miccoli R, Vaccaro O, Rossi E, Bernardi D, De Rosa M, Marchesini G; SID-CINECA ARNO Working Group. Diabetes Care. 2012 Sep;35(9):e64. doi: 10.2337/dc12-0765.
The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory. Marchesini G, Forlani G, Rossi E, Berti A, De Rosa M; ARNO Working Group. Nutr Metab Cardiovasc Dis. 2011 May;21(5):339-46. doi: 10.1016/j.numecd.2009.10.009. Epub 2010 Feb 13.
